Skip to main content

ALYST Health, Premier Concierge Addiction Treatment Program, Adopts SOBRsafe Technology for Client Use

Fully At-Home Alcohol Treatment Program to Offer SOBRsure™ Wearable Band as More Flexible, Humane Accountability Option

DENVER, CO / ACCESSWIRE / February 20, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), providers of next-generation transdermal alcohol detection solutions, today announced that ALYST Health ("ALYST") is adopting the SOBRsafe™ technology for use in its concierge addiction treatment services, the first and only at-home addiction treatment program accredited by The Joint Commission - the nation's oldest and largest health care standards-setting body. ALYST has made an initial purchase of SOBRsure™ alcohol detection wristbands and is integrating them for client use.

"Conventional treatment centers - and conventional monitoring methods - aren't always a good fit for many people who value privacy, personalized treatment or their daily routine," stated ALYST Founder and CEO Richard Blair. "This is why we feel SOBRsure is an ideal addition to our program, which moves the point of care from the treatment center to the comfort and privacy of a client's home - without sacrificing quality. SOBRsure brings dignity and convenience to remote monitoring, and we believe it will further empower recovery success."

Followed SOBRsafe Chairman and CEO Dave Gandini, "We are honored to work with ALYST, a standard-bearer for behavioral health innovation. We both seek to optimize recovery outcomes by looking beyond the walls of traditional treatment."


About SOBRsafe™

Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way.

Enter SOBRsafe™. Our advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration.

The SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure) and licensing/white labeling. At SOBRsafe, we are creating a culture of prevention and support. To learn more, visit

Contact SOBRsafe:

Safe Harbor Statement

Our prospects here at SOBRsafe are subject to uncertainties and risks. This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business, and reflect our beliefs and assumptions based upon information available to us at the date of this press release. In some cases, you can identify these statements by words such as "if," "may," "might," "will, "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue," and other similar terms. These forward-looking statements include, among other things, plans for proposed operations, descriptions of our strategies, our product and market development plans, and other objectives, expectations and intentions, the trends we anticipate in our business and the markets in which we operate, and the competitive nature and anticipated growth of those markets. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors including, but not limited to, the risks and uncertainties discussed under risk factors in our registration statement on Form S-1, (File No. 333-267882) as well as our other filings with the SEC. We undertake no obligation to revise or update any forward-looking statement for any reason.


View the original press release on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.